[
    "**C3 Purification:**",
    " ",
    "Step 1: Isolate Complement factor C3 by PEG precipitation from EDTA-treated human blood plasma and ",
    "Purify by DEAE and blue sepharose affinity chromatography \\(Smith, S.A., _et al._, Biochim Biophys Acta, **1650**, 30-39, 2003). ",
    " ",
    "**C3b preparation:**",
    " ",
    "Step 2: Prepare purified C3b by performing limited trypsin digestion of C3 with sequencing grade trypsin \\(Roche).",
    "Perform the cleavage in the presence of N-Acetlyl-L-Threonine \\(AcT) to provide a nucleophile for covalent attachment of the side chain carbonyl of Gln991.  ",
    "Activate the internal thioester \\(Law, A.S.K. &amp; Dodds, A.W. Protein Science, **6**, 263-274, 1997) with 5% trypsin \\(w/w) for 2 min at 37&#xB0;C, before adding 5% \\(w/w) soybean trypsin inhibitor \\(SBTI) \\(Sigma) to stop the reaction.",
    " ",
    "Step 3: Re",
    "Move trypsin and SBTI by perfusion chromatography using a BioCAD 20HQ column. ",
    " ",
    "Step 4: Visualize C3 and C3b by SDS-PAGE \\(4&#x2013;12% gel) with Coomassie blue staining.  ",
    " ",
    "Step 5: Confirm esterification via mass spectroscopic analysis on tryptic digests of modified C3b. ",
    " ",
    "Step 6: Store modified protein at a concentration of 7.7 mg/ml in 20mM TRIS, pH 7.5 and a protein inhibitor cocktail \\(1M KH2PO4, 0.2 M EDTA, 0.2 M Benzamidine-HCl and 1mM PmSF).",
    " ",
    "**Crystallization:**",
    " ",
    "Step 7: Obtain crystals through vapor diffusion from 2 &#x3BC;l of the protein solution mixed with an equal volume of well solution.  ",
    "Wells should contain 200 mM TRIS, pH 7.5, 100 mM NaCl, 20 mM LiCl and 15% PEG6000."
]